DCM
PARN

Driehaus Capital Management’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Driehaus Capital Management’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-99,663
Closed -$688K – 731
2014
Q2 		$688K Buy
+99,663
New +$766K 0.02% 478

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Driehaus Capital Management's PARN Position: Q3 2014 in Review

Driehaus Capital Management sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q3 2014, closing a stake of 99,663 shares — an estimated $688K sold.

Driehaus Capital Management first reported a position in PARN in Q2 2014 and held it in 1 quarter. The position peaked at $688K in Q2 2014. 15 funds tracked by Wall St. Rank hold PARN as of Q3 2014.

  • Driehaus Capital Management reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q3 2014 after selling out during the quarter.
  • Driehaus Capital Management sold 99,663 Parnell Pharmaceuticals Holdings Ltd shares in Q3 2014, an estimated $688K.
  • Driehaus Capital Management first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q2 2014 and held it in 1 quarter.
  • Driehaus Capital Management's Parnell Pharmaceuticals Holdings Ltd position peaked at $688K in Q2 2014.
  • 15 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q3 2014.

Based on Driehaus Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.